Artículos del autor

solaci

Antiplatelet

ESC 2018 | GLOBAL LEADERS: Ticagrelor Monotherapy Is Not Superior to Classic Therapies After Angioplasty

Dropping aspirin after the first month and continuing with ticagrelor monotherapy was not better than standard dual...
solaci -
Acute coronary syndromes

Report on Cardiovascular Death in Mexico Within the SOLACI-SOCIME 2018 Congress

How can you know if you are having an infarction? What is the rate of cardiovascular death...
solaci -
Fellowship

The Best Pictures of the 9th José Gabay Fellow Course are here

solaci -
Mitral valve

ESC 2018 | MITRA FR: Testing MitraClip for Secondary Mitral Regurgitation

Courtesy of Dr. Carlos Fava. In secondary mitral regurgitation, mitral-valve leaflets and chordae are structurally normal and...
solaci -
Antiplatelet

ESC 2018 | ARRIVE: Aspirin in the Eye of the Storm of Primary Prevention

Aspirin failed to reach the primary endpoint in a population that was at risk of experiencing cardiovascular...
solaci -
Other

ESC 2018 | CLARIFY: No Survival Benefit with Beta-Blockers Beyond 1 Year After Infarction

This is another study that concludes that beta-blockers have no impact on mortality at 1 year after infarction...
solaci -
Antiplatelet

ESC 2018 | ASCEND: Aspirin for Primary Prevention in Diabetic Patients Fails the Cost-Benefit Analysis

The obvious risk of bleeding posed by aspirin was too clear in this work, casting a shadow...
solaci -
Day 3

SOLACI-SOCIME 2018 | Primary angioplasty and cardiogenic shock

Read articles on the main presentations of the first day of SOLACI-SOCIME 2018 Congress. See the presentation by Dr....
solaci -